|8 Easy Ways To Boost Customer Confidence|
In today's market, you need high standards of professionalism to differentiate you from your competitors. Just having the best product or top-notch services isn't enough anymore — customers need to know you care to become loyal. What can you do to help? Read on to learn eight ways you can boost your customers' confidence and show them you're the best place for their business. Download the free infographic now.
German firm develops rapid Dx test for Zika virus
A rapid Zika virus diagnostic assay has been developed by German biotechnology firm Genekam. Researchers said the assay, which can also measure the amount of Zika pathogens in the blood, can only be used in specialized health facilities and laboratories. The test has already been deployed in Brazil for immediate use. TeleSurTV.net (Venezuela)
Merck partners with Cancer Research Technology on drug development
Merck will work with Cancer Research Technology on the development of drugs that inhibit protein arginine methyltransferase 5 for use against cancer and blood disorders. Under the terms of the agreement, Merck will get the development and marketing rights to drugs arising from the collaboration and will give CRT a $15 million upfront payment and as much as $500 million in milestone fees plus sales royalties. PharmaTimes (U.K.)
Biogen building $1.4B facility in Switzerland
Massachusetts-based Biogen is building a $1.4 billion manufacturing facility in Luterbach, Switzerland, that will employ about 400 and triple the company's biologics capacity. Biogen previously announced that it will spend $2.5 billion on Alzheimer's research and development. MedCityNews.com
Wockhardt gets FDA warning over data integrity problems
The FDA said in a January report that India-based pharmaceutical firm Wockhardt removed information from machines and didn't record the outcomes of 22 failed tests. According to the report, a batch of an unapproved Wockhardt treatment was placed in an "approved material" area, and some drugs didn't have expiration dates on their labels. The company is not allowed to ship drugs from its Shendra plant to the US until it has put plans in place to address the data integrity issues and has assured the FDA that the problems are solved. Wockhardt is among several other Indian companies that have been questioned by the FDA in recent months over data integrity issues. Reuters
IPCA Laboratories gets FDA warning for manufacturing violations
A warning letter has been issued by the FDA to IPCA Laboratories over quality violations found at its drug-ingredients plant and finished-drug facilities in India. The company is not allowed to ship drugs from the plants to the US until it has resolved the problems. IPCA is working to fix the issues and is keeping the FDA informed about the steps it is taking. Reuters
Please contact one of our specialists for advertising opportunities,
editorial inquiries, job placements, or any other questions.